Report Cover

Global Clinical Oncology Next Generation Sequencing Market Growth (Status and Outlook) 2021-2026


According to this latest study, the 2021 growth of Clinical Oncology Next Generation Sequencing will have significant change from previous year. By the most conservative estimates of global Clinical Oncology Next Generation Sequencing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Clinical Oncology Next Generation Sequencing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Oncology Next Generation Sequencing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Whole Genome Sequencing
    Whole Exome Sequencing
    Targeted Sequencing & Resequencing Centrifuges

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Hospitals
    Clinics
    Laboratories

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Illumina, Inc.
    Thermo Fisher Scientific
    F. Hoffmann-La Roche Ltd.
    Agilent Technologies
    Myriad Genetics
    Beijing Genomics Institute (BGI)
    Perkin Elmer
    Foundation Medicine
    Pacific Bioscience
    Oxford Nanopore Technologies Ltd.
    Paradigm Diagnostics
    Caris Life Sciences
    Partek, Inc.
    Eurofins Scientific S.E.
    Qiagen N.V.
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Clinical Oncology Next Generation Sequencing Market Size 2016-2026
        2.1.2 Clinical Oncology Next Generation Sequencing Market Size CAGR by Region 2020 VS 2021 VS 2026
    2.2 Clinical Oncology Next Generation Sequencing Segment by Type
        2.2.1 Whole Genome Sequencing
        2.2.2 Whole Genome Sequencing
        2.2.3 Targeted Sequencing & Resequencing Centrifuges
    2.3 Clinical Oncology Next Generation Sequencing Market Size by Type
        2.3.1 Global Clinical Oncology Next Generation Sequencing Market Size CAGR by Type
        2.3.2 Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2016-2021)
    2.4 Clinical Oncology Next Generation Sequencing Segment by Application
        2.4.1 Hospitals
        2.4.2 Clinics
        2.4.3 Laboratories
    2.5 Clinical Oncology Next Generation Sequencing Market Size by Application
        2.5.1 Global Clinical Oncology Next Generation Sequencing Market Size CAGR by Application
        2.5.2 Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2016-2021)

3 Clinical Oncology Next Generation Sequencing Market Size by Players
    3.1 Clinical Oncology Next Generation Sequencing Market Size Market Share by Players
        3.1.1 Global Clinical Oncology Next Generation Sequencing Revenue by Players (2019-2021E)
        3.1.2 Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Players (2019-2021E)
    3.2 Global Clinical Oncology Next Generation Sequencing Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Clinical Oncology Next Generation Sequencing by Regions
    4.1 Clinical Oncology Next Generation Sequencing Market Size by Regions (2016-2021)
    4.2 Americas Clinical Oncology Next Generation Sequencing Market Size Growth (2016-2021)
    4.3 APAC Clinical Oncology Next Generation Sequencing Market Size Growth (2016-2021)
    4.4 Europe Clinical Oncology Next Generation Sequencing Market Size Growth (2016-2021)
    4.5 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Growth (2016-2021)

5 Americas
    5.1 Americas Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021)
    5.2 Americas Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
    5.3 Americas Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Clinical Oncology Next Generation Sequencing Market Size by Region (2016-2021)
    6.2 APAC Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
    6.3 APAC Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Clinical Oncology Next Generation Sequencing by Country (2016-2021)
    7.2 Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
    7.3 Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Clinical Oncology Next Generation Sequencing by Region (2016-2021)
    8.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
    8.3 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Global Clinical Oncology Next Generation Sequencing Market Forecast
    10.1 Global Clinical Oncology Next Generation Sequencing Forecast by Regions (2021-2026)
        10.1.1 Global Clinical Oncology Next Generation Sequencing Forecast by Regions (2021-2026)
        10.1.2 Americas Clinical Oncology Next Generation Sequencing Forecast
        10.1.3 APAC Clinical Oncology Next Generation Sequencing Forecast
        10.1.4 Europe Clinical Oncology Next Generation Sequencing Forecast
        10.1.5 Middle East & Africa Clinical Oncology Next Generation Sequencing Forecast
    10.2 Americas Clinical Oncology Next Generation Sequencing Forecast by Countries (2021-2026)
        10.2.1 United States Clinical Oncology Next Generation Sequencing Market Forecast
        10.2.2 Canada Clinical Oncology Next Generation Sequencing Market Forecast
        10.2.3 Mexico Clinical Oncology Next Generation Sequencing Market Forecast
        10.2.4 Brazil Clinical Oncology Next Generation Sequencing Market Forecast
    10.3 APAC Clinical Oncology Next Generation Sequencing Forecast by Region (2021-2026)
        10.3.1 China Clinical Oncology Next Generation Sequencing Market Forecast
        10.3.2 Japan Clinical Oncology Next Generation Sequencing Market Forecast
        10.3.3 Korea Clinical Oncology Next Generation Sequencing Market Forecast
        10.3.4 Southeast Asia Clinical Oncology Next Generation Sequencing Market Forecast
        10.3.5 India Clinical Oncology Next Generation Sequencing Market Forecast
        10.3.6 Australia Clinical Oncology Next Generation Sequencing Market Forecast
    10.4 Europe Clinical Oncology Next Generation Sequencing Forecast by Country (2021-2026)
        10.4.1 Germany Clinical Oncology Next Generation Sequencing Market Forecast
        10.4.2 France Clinical Oncology Next Generation Sequencing Market Forecast
        10.4.3 UK Clinical Oncology Next Generation Sequencing Market Forecast
        10.4.4 Italy Clinical Oncology Next Generation Sequencing Market Forecast
        10.4.5 Russia Clinical Oncology Next Generation Sequencing Market Forecast
    10.5 Middle East & Africa Clinical Oncology Next Generation Sequencing Forecast by Region (2021-2026)
        10.5.1 Egypt Clinical Oncology Next Generation Sequencing Market Forecast
        10.5.2 South Africa Clinical Oncology Next Generation Sequencing Market Forecast
        10.5.3 Israel Clinical Oncology Next Generation Sequencing Market Forecast
        10.5.4 Turkey Clinical Oncology Next Generation Sequencing Market Forecast
        10.5.5 GCC Countries Clinical Oncology Next Generation Sequencing Market Forecast
    10.6 Global Clinical Oncology Next Generation Sequencing Forecast by Type (2021-2026)
    10.7 Global Clinical Oncology Next Generation Sequencing Forecast by Application (2021-2026)

11 Key Players Analysis
    11.1 Illumina, Inc.
        11.1.1 Illumina, Inc. Company Information
        11.1.2 Illumina, Inc. Clinical Oncology Next Generation Sequencing Product Offered
        11.1.3 Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.1.4 Illumina, Inc. Main Business Overview
        11.1.5 Illumina, Inc. Latest Developments
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Company Information
        11.2.2 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product Offered
        11.2.3 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.2.4 Thermo Fisher Scientific Main Business Overview
        11.2.5 Thermo Fisher Scientific Latest Developments
    11.3 F. Hoffmann-La Roche Ltd.
        11.3.1 F. Hoffmann-La Roche Ltd. Company Information
        11.3.2 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product Offered
        11.3.3 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.3.4 F. Hoffmann-La Roche Ltd. Main Business Overview
        11.3.5 F. Hoffmann-La Roche Ltd. Latest Developments
    11.4 Agilent Technologies
        11.4.1 Agilent Technologies Company Information
        11.4.2 Agilent Technologies Clinical Oncology Next Generation Sequencing Product Offered
        11.4.3 Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.4.4 Agilent Technologies Main Business Overview
        11.4.5 Agilent Technologies Latest Developments
    11.5 Myriad Genetics
        11.5.1 Myriad Genetics Company Information
        11.5.2 Myriad Genetics Clinical Oncology Next Generation Sequencing Product Offered
        11.5.3 Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.5.4 Myriad Genetics Main Business Overview
        11.5.5 Myriad Genetics Latest Developments
    11.6 Beijing Genomics Institute (BGI)
        11.6.1 Beijing Genomics Institute (BGI) Company Information
        11.6.2 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product Offered
        11.6.3 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.6.4 Beijing Genomics Institute (BGI) Main Business Overview
        11.6.5 Beijing Genomics Institute (BGI) Latest Developments
    11.7 Perkin Elmer
        11.7.1 Perkin Elmer Company Information
        11.7.2 Perkin Elmer Clinical Oncology Next Generation Sequencing Product Offered
        11.7.3 Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.7.4 Perkin Elmer Main Business Overview
        11.7.5 Perkin Elmer Latest Developments
    11.8 Foundation Medicine
        11.8.1 Foundation Medicine Company Information
        11.8.2 Foundation Medicine Clinical Oncology Next Generation Sequencing Product Offered
        11.8.3 Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.8.4 Foundation Medicine Main Business Overview
        11.8.5 Foundation Medicine Latest Developments
    11.9 Pacific Bioscience
        11.9.1 Pacific Bioscience Company Information
        11.9.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing Product Offered
        11.9.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.9.4 Pacific Bioscience Main Business Overview
        11.9.5 Pacific Bioscience Latest Developments
    11.10 Oxford Nanopore Technologies Ltd.
        11.10.1 Oxford Nanopore Technologies Ltd. Company Information
        11.10.2 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product Offered
        11.10.3 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.10.4 Oxford Nanopore Technologies Ltd. Main Business Overview
        11.10.5 Oxford Nanopore Technologies Ltd. Latest Developments
    11. Paradigm Diagnostics
        11.11.1 Paradigm Diagnostics Company Information
        11.11.2 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product Offered
        11.11.3 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.11.4 Paradigm Diagnostics Main Business Overview
        11.11.5 Paradigm Diagnostics Latest Developments
    11.12 Caris Life Sciences
        11.12.1 Caris Life Sciences Company Information
        11.12.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing Product Offered
        11.12.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.12.4 Caris Life Sciences Main Business Overview
        11.12.5 Caris Life Sciences Latest Developments
    11.13 Partek, Inc.
        11.13.1 Partek, Inc. Company Information
        11.13.2 Partek, Inc. Clinical Oncology Next Generation Sequencing Product Offered
        11.13.3 Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.13.4 Partek, Inc. Main Business Overview
        11.13.5 Partek, Inc. Latest Developments
    11.14 Eurofins Scientific S.E.
        11.14.1 Eurofins Scientific S.E. Company Information
        11.14.2 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product Offered
        11.14.3 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.14.4 Eurofins Scientific S.E. Main Business Overview
        11.14.5 Eurofins Scientific S.E. Latest Developments
    11.15 Qiagen N.V.
        11.15.1 Qiagen N.V. Company Information
        11.15.2 Qiagen N.V. Clinical Oncology Next Generation Sequencing Product Offered
        11.15.3 Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
        11.15.4 Qiagen N.V. Main Business Overview
        11.15.5 Qiagen N.V. Latest Developments

12 Research Findings and Conclusion

List of Tables Table 1. Clinical Oncology Next Generation Sequencing Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Whole Genome Sequencing Table 3. Major Players of Whole Exome Sequencing Table 4. Major Players of Targeted Sequencing & Resequencing Centrifuges Table 5. Clinical Oncology Next Generation Sequencing Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) & ($ Millions) Table 7. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2016-2021) Table 8. Clinical Oncology Next Generation Sequencing Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) & ($ Millions) Table 10. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2016-2021) Table 11. Global Clinical Oncology Next Generation Sequencing Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Players (2019-2021E) Table 13. Clinical Oncology Next Generation Sequencing Key Players Head office and Products Offered Table 14. Clinical Oncology Next Generation Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Clinical Oncology Next Generation Sequencing Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Regions 2016-2021 Table 19. Americas Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Country (2016-2021) Table 21. Americas Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2016-2021) Table 23. Americas Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2016-2021) Table 25. APAC Clinical Oncology Next Generation Sequencing Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Region (2016-2021) Table 27. APAC Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2016-2021) Table 29. APAC Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2016-2021) Table 31. Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Country (2016-2021) Table 33. Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2016-2021) Table 35. Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of Clinical Oncology Next Generation Sequencing Table 44. Key Application and Potential Industries of Clinical Oncology Next Generation Sequencing Table 45. Key Challenges of Clinical Oncology Next Generation Sequencing Table 46. Key Trends of Clinical Oncology Next Generation Sequencing Table 47. Global Clinical Oncology Next Generation Sequencing Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global Clinical Oncology Next Generation Sequencing Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global Clinical Oncology Next Generation Sequencing Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global Clinical Oncology Next Generation Sequencing Market Size Market Share Forecast by Type (2021-2026) Table 51. Global Clinical Oncology Next Generation Sequencing Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global Clinical Oncology Next Generation Sequencing Market Size Market Share Forecast by Application (2021-2026) Table 53. Illumina, Inc. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 54. Illumina, Inc. Clinical Oncology Next Generation Sequencing Product Offered Table 55. Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. Illumina, Inc. Main Business Table 57. Illumina, Inc. Latest Developments Table 58. Thermo Fisher Scientific Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 59. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product Offered Table 60. Thermo Fisher Scientific Main Business Table 61. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Thermo Fisher Scientific Latest Developments Table 63. F. Hoffmann-La Roche Ltd. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 64. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product Offered Table 65. F. Hoffmann-La Roche Ltd. Main Business Table 66. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. F. Hoffmann-La Roche Ltd. Latest Developments Table 68. Agilent Technologies Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 69. Agilent Technologies Clinical Oncology Next Generation Sequencing Product Offered Table 70. Agilent Technologies Main Business Table 71. Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. Agilent Technologies Latest Developments Table 73. Myriad Genetics Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 74. Myriad Genetics Clinical Oncology Next Generation Sequencing Product Offered Table 75. Myriad Genetics Main Business Table 76. Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. Myriad Genetics Latest Developments Table 78. Beijing Genomics Institute (BGI) Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 79. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product Offered Table 80. Beijing Genomics Institute (BGI) Main Business Table 81. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Beijing Genomics Institute (BGI) Latest Developments Table 83. Perkin Elmer Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 84. Perkin Elmer Clinical Oncology Next Generation Sequencing Product Offered Table 85. Perkin Elmer Main Business Table 86. Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. Perkin Elmer Latest Developments Table 88. Foundation Medicine Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 89. Foundation Medicine Clinical Oncology Next Generation Sequencing Product Offered Table 90. Foundation Medicine Main Business Table 91. Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. Foundation Medicine Latest Developments Table 93. Pacific Bioscience Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 94. Pacific Bioscience Clinical Oncology Next Generation Sequencing Product Offered Table 95. Pacific Bioscience Main Business Table 96. Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 97. Pacific Bioscience Latest Developments Table 98. Oxford Nanopore Technologies Ltd. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 99. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product Offered Table 100. Oxford Nanopore Technologies Ltd. Main Business Table 101. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 102. Oxford Nanopore Technologies Ltd. Latest Developments Table 103. Paradigm Diagnostics Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 104. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product Offered Table 105. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 106. Paradigm Diagnostics Main Business Table 107. Paradigm Diagnostics Latest Developments Table 108. Caris Life Sciences Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 109. Caris Life Sciences Clinical Oncology Next Generation Sequencing Product Offered Table 110. Caris Life Sciences Main Business Table 111. Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 112. Caris Life Sciences Latest Developments Table 113. Partek, Inc. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 114. Partek, Inc. Clinical Oncology Next Generation Sequencing Product Offered Table 115. Partek, Inc. Main Business Table 116. Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 117. Partek, Inc. Latest Developments Table 118. Eurofins Scientific S.E. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 119. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product Offered Table 120. Eurofins Scientific S.E. Main Business Table 121. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 122. Eurofins Scientific S.E. Latest Developments Table 123. Qiagen N.V. Details, Company Type, Clinical Oncology Next Generation Sequencing Area Served and Its Competitors Table 124. Qiagen N.V. Clinical Oncology Next Generation Sequencing Product Offered Table 125. Qiagen N.V. Main Business Table 126. Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 127. Qiagen N.V. Latest Developments List of Figures Figure 1. Clinical Oncology Next Generation Sequencing Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Clinical Oncology Next Generation Sequencing Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Type in 2020 Figure 7. Clinical Oncology Next Generation Sequencing in Hospitals Figure 8. Global Clinical Oncology Next Generation Sequencing Market: Hospitals (2016-2021) & ($ Millions) Figure 9. Clinical Oncology Next Generation Sequencing in Clinics Figure 10. Global Clinical Oncology Next Generation Sequencing Market: Clinics (2016-2021) & ($ Millions) Figure 11. Clinical Oncology Next Generation Sequencing in Laboratories Figure 12. Global Clinical Oncology Next Generation Sequencing Market: Laboratories (2016-2021) & ($ Millions) Figure 13. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2020 Figure 14. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Player in 2020 Figure 15. Global Clinical Oncology Next Generation Sequencing Market Size Market Share by Regions (2016-2021) Figure 16. Americas Clinical Oncology Next Generation Sequencing Market Size 2016-2021 ($ Millions) Figure 17. APAC Clinical Oncology Next Generation Sequencing Market Size 2016-2021 ($ Millions) Figure 18. Europe Clinical Oncology Next Generation Sequencing Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size 2016-2021 ($ Millions) Figure 20. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Country in 2020 Figure 21. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Type in 2020 Figure 22. Americas Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2020 Figure 23. United States Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Regions in 2020 Figure 27. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Type in 2020 Figure 28. APAC Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2020 Figure 29. China Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 33. India Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Country in 2020 Figure 36. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Type in 2020 Figure 37. Europe Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2020 Figure 38. Germany Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 39. France Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Market Share by Application in 2020 Figure 46. Egypt Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Clinical Oncology Next Generation Sequencing Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 52. APAC Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 53. Europe Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 55. United States Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 56. Canada Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 57. Mexico Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 58. Brazil Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 59. China Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 60. Japan Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 61. Korea Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 63. India Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 64. Australia Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 65. Germany Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 66. France Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 67. UK Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 68. Italy Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 69. Russia Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 70. Spain Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 71. Egypt Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 72. South Africa Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 73. Israel Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 74. Turkey Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Clinical Oncology Next Generation Sequencing Market Size 2021-2026 ($ Millions)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us